STOCK TITAN
  1. Home
  2. News
  3. CAH

Cardinal Health, Inc. - CAH STOCK NEWS

Welcome to our dedicated news page for Cardinal Health (Ticker: CAH), a resource for investors and traders seeking the latest updates and insights on Cardinal Health.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Cardinal Health's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Cardinal Health's position in the market.

News
Cardinal Health Reaffirms Fiscal 2024 non-GAAP EPS Guidance and Long-term Targets Amidst Nonrenewal of OptumRx Customer Contracts
Rhea-AI Summary
Cardinal Health reaffirms its fiscal 2024 non-GAAP EPS guidance and long-term targets despite the nonrenewal of OptumRx customer contracts. The company expects sustained growth, attractive returns for shareholders, and profitability in fiscal 2025 through new customer wins, specialty growth, and other actions.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
earnings
-
News
Cardinal Health announces location of pharmaceutical distribution center for over-the-counter products
Rhea-AI Summary
Cardinal Health (CAH) initiates construction of a new 350,000 square-foot Consumer Health Logistics Center in Columbus, Ohio. The center aims to enhance distribution of over-the-counter consumer health products, creating 100 new jobs and improving supply chain resiliency.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.72%
Tags
none
-
News
Cardinal Health to Announce Third-Quarter Results for Fiscal Year 2024 on May 2
Rhea-AI Summary
Cardinal Health (CAH) is set to announce its third-quarter financial results for fiscal year 2024 on May 2, 2024. The company will host a webcast to discuss the results at 8:30 a.m. Eastern time. Investors can access the webcast and presentation slides on Cardinal Health's Investor Relations page without needing an access code. A replay of the webcast will also be available for 12 months.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.53%
Tags
earnings
News
Cardinal Health announces approved science-based climate targets; expands focus across the supply chain
Rhea-AI Summary
Cardinal Health (CAH) secures approval for science-based greenhouse gas emissions reduction targets, showing commitment to sustainability and environmental responsibility.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.62%
Tags
none
-
News
Cardinal Health annual research report examines milestone year in biosimilars
Rhea-AI Summary
Cardinal Health releases its 2024 Biosimilars Report, highlighting the impact of biosimilars on patient accessibility and treatment affordability. The report covers legislative developments, new treatments like adalimumab biosimilars, and perspectives from retina specialists. It emphasizes the importance of biosimilars in reducing healthcare costs and increasing care accessibility.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.29%
Tags
none
-
News
Bob Azelby to join Cardinal Health Board of Directors
Rhea-AI Summary
Cardinal Health appoints Robert Azelby as an independent director, bringing over 30 years of experience in the healthcare industry. His vast expertise in specialty pharmaceuticals, oncology, and biopharmaceuticals will enhance Cardinal Health's strategic priorities.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.29%
Tags
management
News
Cardinal Health Board of Directors Approves Quarterly Dividend
Rhea-AI Summary
Cardinal Health (NYSE: CAH) has declared a quarterly dividend of $0.5006 per share, payable on April 15, 2024, to shareholders of record at the close of business on April 1, 2024.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.54%
Tags
management dividends
-
News
Cardinal Health publishes Fiscal 2023 Environmental, Social and Governance (ESG) Report
Rhea-AI Summary
Cardinal Health (NYSE: CAH) has announced its financial results for the fourth quarter of 2023, reporting a revenue increase of 5% year-over-year. The company's pharmaceutical segment saw strong growth, driven by higher sales of generic drugs. However, the medical segment experienced a decline in revenue due to lower sales of medical devices. Cardinal Health also revealed plans to invest in expanding its pharmaceutical distribution network.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.42%
Tags
earnings
-
News
Cardinal Health Reports Second Quarter Fiscal 2024 Results and Raises Fiscal 2024 Outlook
Rhea-AI Summary
Cardinal Health reported a 12% increase in revenue to $57.4 billion for the second quarter of fiscal 2024. GAAP operating earnings were $482 million, and GAAP diluted EPS was $1.43. Non-GAAP operating earnings increased by 20% to $562 million, and non-GAAP diluted EPS increased by 38% to $1.82. The company raised its fiscal 2024 non-GAAP EPS guidance to $7.20 to $7.35 and non-GAAP adjusted free cash flow guidance to ~$2.5 billion. Cardinal Health also announced the acquisition of Specialty Networks, a technology-enabled multi-specialty group purchasing and practice enhancement organization.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.75%
Tags
earnings
News
Cardinal Health to acquire Specialty Networks and its PPS Analytics platform, a technology enabled multi-specialty group purchasing and practice enhancement organization in urology, rheumatology and gastroenterology
Rhea-AI Summary
Cardinal Health (NYSE: CAH) has announced the acquisition of Specialty Networks for $1.2B in cash, expanding its specialty strategy and creating increased clinical and economic value for independent specialty providers. The acquisition is expected to enhance the company's downstream provider-focused analytics capabilities and service offerings and accelerate its upstream data and research opportunities with biopharma manufacturers.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.99%
Tags
acquisition
Stock CAH logo
Cardinal Health, Inc.

NYSE:CAH

CAH Rankings

#428 Ranked by Market Cap
#905 Ranked by Stock Gains
#1439 Ranked by Dividends

CAH Stock Data

25.56B
241.94M
0.58%
90.15%
3.72%
Drugs and Druggists' Sundries Merchant Wholesalers
Wholesale Trade
Link
US
Dublin

About CAH

cardinal health, inc. (nyse: cah), is a global integrated healthcare services and products company, providing customized solutions for hospital systems, pharmacies, ambulatory surgery centers, clinical laboratories and physician offices worldwide. the company provides clinically-proven medical products and pharmaceuticals and cost-effective solutions that enhance supply chain efficiency. cardinal health connects patients, providers, payers, pharmacists and manufacturers for integrated care coordination and better patient management. backed by nearly 100 years of experience, with more than 37,000 employees in nearly 60 countries, cardinal health ranks among the top 25 on the fortune 500. for more information, visit cardinalhealth.com, follow @cardinalhealth on twitter.